![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
A Pap and CW Bradberry
Department of Psychiatry, Yale University School of Medicine, Connecticut, USA.
The effect of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5- methylisoxazole-4-propionate/kainate excitatory amino acid antagonists on systemic cocaine-induced increases in extracellular dopamine was examined. The alpha-amino-3-hydroxy-5-methylisoxazole-4- propionate/kainate receptor subtype antagonist, 6-cyano-7- nitroquinoxaline-2,3-dione (CNQX), and N-methyl-D-aspartate receptor antagonists, 2-amino-5-phosphonovalerate and dizocilpine, were infused via a microdialysis probe placed in the nucleus accumbens. The local infusion of 2-amino-5-phosphonovalerate (500 microM), dizocilpine (50 microM) and CNQX (100 microM), started 80 min before cocaine injection, significantly inhibited the cocaine-induced increase in extracellular dopamine. The CNQX blockade was dose-dependent with respect to both CNQX concentration infused and dose of cocaine administered. Simultaneous infusion of the two antagonists (500 microM 2-amino-5- phosphonovalerate and 100 microM CNQX) did not lead to further reductions in the effects of cocaine when compared to either antagonist alone. Our results suggest that both N-methyl-Daspartate and alpha- amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate subtypes of excitatory amino acid antagonist receptors may contribute to the stimulatory effect of cocaine on extracellular dopamine in the nucleus accumbens.
This article has been cited by other articles:
|
|
 |
|
  P. Di Ciano, R. N. Cardinal, R. A. Cowell, S. J. Little, and B. J. Everitt Differential Involvement of NMDA, AMPA/Kainate, and Dopamine Receptors in the Nucleus Accumbens Core in the Acquisition and Performance of Pavlovian Approach Behavior J. Neurosci., December 1, 2001; 21(23): 9471 - 9477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Robbe, G. Alonso, F. Duchamp, J. Bockaert, and O. J. Manzoni Localization and Mechanisms of Action of Cannabinoid Receptors at the Glutamatergic Synapses of the Mouse Nucleus Accumbens J. Neurosci., January 1, 2001; 21(1): 109 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Swanson and P. W. Kalivas Regulation of Locomotor Activity by Metabotropic Glutamate Receptors in the Nucleus Accumbens and Ventral Tegmental Area J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 406 - 414. [Abstract] [Full Text]
|
|
|
|
|
|
G. Hu, P. Duffy, C. Swanson, M. B. Ghasemzadeh, and P. W. Kalivas The Regulation of Dopamine Transmission by Metabotropic Glutamate Receptors J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 412 - 416. [Abstract] [Full Text]
|
|
|
|
|
|
J.-H. Kim and P. Vezina Metabotropic Glutamate Receptors in the Rat Nucleus Accumbens Contribute to Amphetamine-Induced Locomotion J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 317 - 322. [Abstract] [Full Text]
|
|
|
|
|
|
J.-H. Kim and P. Vezina Activation of Metabotropic Glutamate Receptors in the Rat Nucleus Accumbens Increases Locomotor Activity in a Dopamine-Dependent Manner J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 962 - 968. [Abstract] [Full Text]
|
|
|
|
|
|
B. Moghaddam, B. Adams, A. Verma, and D. Daly Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex J. Neurosci., April 15, 1997; 17(8): 2921 - 2927. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
